RP-HPLC ANALYSIS METHOD OF BISOPROLOL FUMARATE IN A NEW TABLET FORMULATION

  • Alina Diana PANAINTE “Grigore T. Popa” University of Medicine and Pharmacy Iasi
  • Madalina VIERIU “Grigore T. Popa” University of Medicine and Pharmacy Iasi
  • Gladiola TANTARU “Grigore T. Popa” University of Medicine and Pharmacy Iasi
  • M. APOSTU “Grigore T. Popa” University of Medicine and Pharmacy Iasi
  • Nela BIBIRE “Grigore T. Popa” University of Medicine and Pharmacy Iasi
  • Liliana AVASILCAI “Grigore T. Popa” University of Medicine and Pharmacy Iasi
  • Ionela Daniela MORARIU “Grigore T. Popa” University of Medicine and Pharmacy Iasi

Abstract

RP-HPLC ANALYSIS METHOD OF BISOPROLOL FUMARATE IN A NEW TABLET FORMULATION (Abstract): Aim: Development of a new HPLC method for the quantitative determination of bisoprolol fumarate in a novel sustained release tablet formulation. Material and methods: The sustained release matrix tablets with bisoprolol fumarate were formulated using an innovative combination of hydroxypropyl methylcellulose and Precirol ATO5 as excipients. The HPLC separation was done using an Agilent Eclipse XDB-C18 column (150 mm ´ 4.6 mm, 5 µm) and a mobile phase consisting of acetonitrile 10 mM and pH 4.5 phosphate buffer solution (10:90, v/v) at a flow rate of 1.0 mL/min. The method was validated according to ICH guidelines in terms of accuracy, precision, linearity and robustness. Results: Bisoprolol fumarate was separated in less than 4 minutes with good resolution and without any tailing effect or excipient interference. The limit of detection and the limit of quantification were 2.79 and 3.07 µg/mL, respectively. The relative standard deviation evaluated for the precision of the method was lower than 1%. Conclusions: The HPLC method developed for the determination of bisoprolol fumarate in a novel sustained release tablet formulation was specific and simple and it could also be used for in vitro studies.

Author Biographies

Alina Diana PANAINTE, “Grigore T. Popa” University of Medicine and Pharmacy Iasi

Faculty of Pharmacy
Department of Analytical Chemistry

Madalina VIERIU, “Grigore T. Popa” University of Medicine and Pharmacy Iasi

Faculty of Pharmacy
Department of Analytical Chemistry

Gladiola TANTARU, “Grigore T. Popa” University of Medicine and Pharmacy Iasi

Faculty of Pharmacy
Department of Analytical Chemistry

M. APOSTU, “Grigore T. Popa” University of Medicine and Pharmacy Iasi

Faculty of Pharmacy
Department of Analytical Chemistry

Nela BIBIRE, “Grigore T. Popa” University of Medicine and Pharmacy Iasi

Faculty of Pharmacy
Department of Analytical Chemistry

Liliana AVASILCAI, “Grigore T. Popa” University of Medicine and Pharmacy Iasi

Faculty of Pharmacy
Department of Environmental Chemistry

Ionela Daniela MORARIU, “Grigore T. Popa” University of Medicine and Pharmacy Iasi

Faculty of Pharmacy
Department of Environmental Chemistry

References

1. Mark N. Drug treatment of elevated blood pressure. Aust Prescr 2010; (33): 108-112.
2. Postolache P, Cojocaru DC, Jimborean G, Ianosi ES. Outcomes of pulmonary rehabilitation in severe pulmonary hypertension – case report. Rev Med Chir Soc Med Nat Iasi 2018; 122 (1): 67-71.
3. Gherman S, Zavastin D, Şpac A, Mircea C, Ştefanache A, Pascu LF, et al. Development and validation of a capillary electrophoretic method for the determination of enalapril. Rev Chim (Bucuresti) 2015; 66 (10): 1577-1581.
4. Bhagwat DA, Kawtikwar PS, Sakarkar DM. Formulation and the in vitro and biopharmaceutical evaluation of sustained release tablet of verapamil HCL using precirol ATO 5 through melt granulation technique. A J Pharm 2009; 3(4): 278-285.
5. Jannat E, Al Arif A, Mehdi Hasan M, Bin Zarziz A, Ar Rashid H. Granulation techniques & its up-dated modules. J Pharm Innov 2016; 5(10): 134-141.
6. Picker-Freyer KM, Dürig T. Physical mechanical and tablet formation properties of hydroxypropyl cellulose: in pure form and in mixtures. AAPS Pharm Sci Tech 2007; 8: 82-90.
7. Mahu SC, Şpac AF, Ciobanu C, Butnaru E. Quantitative Determination of bisoprolol fumarate by HPLC. I. Method validation. Rev Chim (Bucuresti) 2016; 67(3): 414-417.
8. Kondratova Y, Logoyda L, Voloshko Y, Megied AA, Korobko D, Soroka Y. Development and vali-dation of HPLC-DAD method for the determination of bisoprolol in tablet dosage forms. Int J App Pharm 2017; 9(6): 54-59.
9. Zil’berga RA, Yarkaevaa YuA, Sidel’nikova AV, Maistrenkoa VN, Kraikinb VA, Gilevab NG. Volt-ammetric Determination of Bisoprolol on a Glassy Carbon Electrode Modified by Poly (Arylene Phthalide). J Anal Chem 2016; 71(9): 926-931.
10. Bozal B, Gumustas M, Dogan-Topal B, Uslu B, Ozkan SA. Fully validated simultaneous determination of bisoprolol fumarate and hydrochlorothiazide in their dosage forms using different voltammetry, chromatographic, and spectrophotometric analytical methods. J AOAC Int 2013; 96(1): 42-51.
11. Ulu ST, Kel E. Spectrophotometric determination of bisoprolol in pharmaceutical preparations by charge transfer reactions. Opt Spektrosk 2012; 112: 864-867.
12. Kumbhar ST, Shinde PP, Shinde DB, Solankar PB. Visible spectrophotometric method for estimation of bisoprolol from its bulk and tablet formulation. Asian J Pharm Clin Res 2013; 6: 103-105.
13. Tilea I, Popa D, Muntean DL, Bocicor AE, Vlase L, Tilea B. Determination of Bisoprolol in Human Plasma by Lc-ms/ms for Therapeutic Drug Monitoring. Exp Clin Cardiol 2016; 20(1): 2236-2245.
14. Peste G, Bibire N, Apostu M, Vlase A, Oniscu C. A new liquid chromatography-tandem mass spec-trometry method for determination of bisoprolol in human plasma samples. J Biomed Biotechnol 2009; 736327. doi: 10.1155/2009/736327.
15. ***ICH Topic Q2B: Validation of Analytical Procedures (CPMP/ICH/281/95). The European Agency for the Evaluation of Medicinal Products.
16. Bose A. HPLC calibration process parameters in terms of system suitability test. Austin Chromatogr 2014; 1(2): 4-6.
17. Tătărîngă G, Stan C, Mircea C, Jitareanu A, Zbancioc AM. Antioxidant Evaluation of Some Coumarin Derivatives. Farmacia 2016; 64(4): 533-538.
18. Balint A, Imre S, Bondoroi-Papp Z, Muntean DL. Development of a new RP-HPLC method for on-dansetron determination in injectable formulations. Rev Med Chir Soc Med Nat Iasi 2018; 122(1): 207-212.
19. Stan CD, Ştefanache A, Tuchiluş C, Diaconu DE, Drăgan M, Profire L. Influence of extraction solvent on the erythromycin ethyl succinate separation from oral suspendable powder. Farmacia 2011; 59(3): 396-401.
Published
2018-10-04